1. Home
  2. AYTU vs AUST Comparison

AYTU vs AUST Comparison

Compare AYTU & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • AUST
  • Stock Information
  • Founded
  • AYTU N/A
  • AUST 2020
  • Country
  • AYTU United States
  • AUST Canada
  • Employees
  • AYTU N/A
  • AUST N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • AUST
  • Sector
  • AYTU Health Care
  • AUST
  • Exchange
  • AYTU Nasdaq
  • AUST Nasdaq
  • Market Cap
  • AYTU 18.8M
  • AUST 21.1M
  • IPO Year
  • AYTU N/A
  • AUST 2022
  • Fundamental
  • Price
  • AYTU $2.37
  • AUST N/A
  • Analyst Decision
  • AYTU Strong Buy
  • AUST
  • Analyst Count
  • AYTU 3
  • AUST 0
  • Target Price
  • AYTU $9.17
  • AUST N/A
  • AVG Volume (30 Days)
  • AYTU 393.1K
  • AUST 213.2K
  • Earning Date
  • AYTU 11-12-2025
  • AUST 11-05-2025
  • Dividend Yield
  • AYTU N/A
  • AUST N/A
  • EPS Growth
  • AYTU N/A
  • AUST N/A
  • EPS
  • AYTU N/A
  • AUST N/A
  • Revenue
  • AYTU $66,382,000.00
  • AUST N/A
  • Revenue This Year
  • AYTU N/A
  • AUST N/A
  • Revenue Next Year
  • AYTU $19.03
  • AUST N/A
  • P/E Ratio
  • AYTU N/A
  • AUST N/A
  • Revenue Growth
  • AYTU 1.84
  • AUST N/A
  • 52 Week Low
  • AYTU $0.95
  • AUST $1.05
  • 52 Week High
  • AYTU $2.82
  • AUST $3.19
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 57.62
  • AUST 72.35
  • Support Level
  • AYTU $1.65
  • AUST $1.88
  • Resistance Level
  • AYTU $1.98
  • AUST $2.30
  • Average True Range (ATR)
  • AYTU 0.16
  • AUST 0.20
  • MACD
  • AYTU 0.03
  • AUST 0.04
  • Stochastic Oscillator
  • AYTU 70.30
  • AUST 95.21

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About AUST Austin Gold Corp.

Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).

Share on Social Networks: